Vibativ - NDC Database
7 records found
Page:
0469-3525 Nov 05, 2009
Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
0469-3575 Nov 05, 2009
Vibativ 750 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
Vibativ 750 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
52118-001 Nov 05, 2009
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
52118-002 Nov 05, 2009
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
62847-001 Nov 05, 2009
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
62847-002 Nov 05, 2009
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
66220-315 Jan 01, 2021
Vibativ 15 mg/mg Intravenous Injection, Powder, Lyophilized, for Solution by Cumberland Pharmaceuticals Inc.
Vibativ 15 mg/mg Intravenous Injection, Powder, Lyophilized, for Solution by Cumberland Pharmaceuticals Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.